Patent · US Active

Peptidomimetics comprising N-amino cyclic urea residues and uses thereof

US8993515B2 · kind B2 · utility

1Cited by
0References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 5, 2013
Grant dateMar 31, 2015
Priority date
Expiry dateJun 5, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel peptidomimetics comprising N-amino cyclic urea residues are disclosed. Use of such peptidomimetics for modulating the activity of CD36 or IL-1 receptor in a cell, and for treating CD36- or IL-1-related disease, disorder or condition is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.